Informazioni generali
  • Categoria della malattia Malattie neonatali (BASEC)
  • Stato di reclutamento Sconosciuto (BASEC/ICTRP)
  • Luogo dello studio
    Berna, Zurigo
    (BASEC)
  • Responsabile dello studio Stephanie Brezina ngn.mit-pb-studie@usz.ch (BASEC)
  • Fonte dati BASEC: Importato da 27.09.2024 ICTRP: N/A
  • Ultimo aggiornamento 27.09.2024 10:28
HumRes61017 | SNCTP000005204 | BASEC2022-01519

Movement Imitation Therapy for Preterm Babies (MIT-PB): What influence does this early intervention have on the neuromotor development of preterm children with atypical spontaneous motor activity (General Movements)?

  • Categoria della malattia Malattie neonatali (BASEC)
  • Stato di reclutamento Sconosciuto (BASEC/ICTRP)
  • Luogo dello studio
    Berna, Zurigo
    (BASEC)
  • Responsabile dello studio Stephanie Brezina ngn.mit-pb-studie@usz.ch (BASEC)
  • Fonte dati BASEC: Importato da 27.09.2024 ICTRP: N/A
  • Ultimo aggiornamento 27.09.2024 10:28

Descrizione riassuntiva dello studio

The Movement Imitation Therapy for Preterm Babies (MIT-PB) by Dr. Marina Soloveichick is a new treatment method for preterm infants that has been little studied so far. This study aims to find out whether the new treatment method has a greater positive influence on neuromotor development than conventional physiotherapy. To investigate this, there will be a control group and an intervention group, each with approximately 40 children. The children included in the study from the neonatology department of Inselspital Bern form the control group. The children included in the study from the neonatology clinic of USZ in Zurich form the intervention group. The children in the control group will be treated with conventional physiotherapy. Apart from documenting the frequency and contents of the treatments, nothing will change in the treatment. The children in the intervention group will be treated with conventional physiotherapy and additionally with MIT-PB. The parents will be introduced to the treatment so that they can carry out most of the treatment independently. They will be accompanied and supported by trained physiotherapists both in the hospital and after discharge. The treatment will be carried out until the age of 52 weeks (corrected three months). All children will undergo a test at 40 weeks, corrected three months, and two years to assess the child's neuromotor development status. Parents will be asked to complete a short self-efficacy questionnaire (PMP S-E) at the beginning of the study and at the three-month check-up. The total duration of the study per child is approximately 26 months.

(BASEC)

Intervento studiato

The children in the intervention group will be treated in addition to conventional physiotherapeutic treatment by the physiotherapist and/or by the parents with MIT-PB. The MIT-PB starts in neonatology and continues at home until the age of 52 weeks. Essential in this treatment method according to Dr. Marina Soloveichick is the manual redirection of atypical spontaneous movements towards as fluid and variable movements as possible. The child should be awake, content, and active during the treatment. The MIT-PB should be applied 5 times a day for 10 minutes.

(BASEC)

Malattie studiate

The neuromotor development of preterm children (under 32 weeks of gestation) with a high risk of mild to severe neuromotor developmental impairment.

(BASEC)

Criteri di partecipazione
Children born before 32 weeks of gestation (in the neonatology clinic at USZ or the neonatology department of Inselspital Bern) and showing atypical General Movements (spontaneous movements) at 33-34 weeks of gestation and/or having a brain hemorrhage grade 3 or higher. (BASEC)

Criteri di esclusione
Comorbidities that could further restrict the motor behavior of preterm children (such as syndromic diseases, neuromuscular diseases, or diseases affecting the musculature and/or the skeletal system) (BASEC)

Luogo dello studio

Berna, Zurigo

(BASEC)

non disponibile

Sponsor

non disponibile

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

Stephanie Brezina

+41 44 255 92 78

ngn.mit-pb-studie@usz.ch

(BASEC)

Informazioni scientifiche

non disponibile

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione etica Zurigo

(BASEC)

Data di approvazione del comitato etico

04.11.2022

(BASEC)


ID di studio ICTRP
non disponibile

Titolo ufficiale (approvato dal comitato etico)
non disponibile

Titolo accademico
non disponibile

Titolo pubblico
non disponibile

Malattie studiate
non disponibile

Intervento studiato
non disponibile

Tipo di studio
non disponibile

Disegno dello studio
non disponibile

Criteri di inclusione/esclusione
non disponibile

non disponibile

Endpoint primari e secondari
non disponibile

non disponibile

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
non disponibile

ID secondari
non disponibile

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
non disponibile

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile